Baby Safety / Compounds / Kojic acid

Is Kojic acid safe for babies and kids?

Context-dependent for kids

(Babies-specific data is limited; this page draws from human pregnant context.) Pregnancy alters the metabolism and distribution of Kojic acid, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

What is kojic acid?

The IUPAC name is 5-hydroxy-2-(hydroxymethyl)pyran-4-one.

Also known as: 5-hydroxy-2-(hydroxymethyl)pyran-4-one, 5-Hydroxy-2-(hydroxymethyl)-4H-pyran-4-one, 5-Hydroxy-2-(hydroxymethyl)-4-pyrone, 4H-PYRAN-4-ONE, 5-HYDROXY-2-(HYDROXYMETHYL)-.

IUPAC name
5-hydroxy-2-(hydroxymethyl)pyran-4-one
CAS number
501-30-4
Molecular formula
C6H6O4
Molecular weight
142.11 g/mol
SMILES
C1=C(OC=C(C1=O)O)CO
PubChem CID
3840

Risk for babies

Context-dependent

Pregnancy alters the metabolism and distribution of Kojic acid, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of Kojic acid, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

5 regulatory and scientific bodies have classified Kojic acid. The classifications differ — that's the data.

AgencyYearClassificationNotes
US EPA2000not classifiable as to human carcinogenicity (Group D)
EFSA2014not established as carcinogenic; SCCS (Scientific Committee on Consumer Safety) Opinion SCCS/1522/13 (2014) found kojic acid safe at 1% in face and hand cosmetics based on available data; prior SCCS opinion (2010) found inadequate data and deferred assessment; thyroid effects at high systemic doses in rodents not considered relevant to dermal cosmetic exposure at low concentrations; sensitization is a documented concern
EPA CTX / IARC—Group 3 - Not classifiable as to its carcinogenicity to humans
EPA CTX / Genetox—Genotoxicity: positive (Ames: positive, 5 positive / 4 negative reports)
EPA CTX / Genetox—Genotoxicity: positive (Ames: positive, 5 positive / 4 negative reports)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter kojic acid

  • Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational Environments — Factories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Kojic acid:

  • Tocopherol (Vitamin E) based antioxidants
    Trade-offs: Lower thermal stability than synthetic BHT/BHA for some polymer applications.
    Relative cost: 2-5× conventional

Frequently asked questions

What products contain kojic acid?

Kojic acid appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

Why do regulators disagree about kojic acid?

Kojic acid has been classified by 5 agencies including US EPA, EFSA, EPA CTX / IARC, EPA CTX / Genetox, EPA CTX / Genetox, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.

See Kojic acid in the baby app

Look up products containing kojic acid, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (2)
  1. US EPA Kojic Acid: Group D Not Classifiable; Rodent Thyroid Follicular Adenomas at High Dose; Tyrosinase Copper Chelation Mechanism; No FDA OTC Skin Lightening Monograph; Japan MHLW Quasi-Drug 1%; Contact Sensitization 1–3% (2000) — regulatory
  2. EFSA/SCCS Kojic Acid Opinion SCCS/1522/13: Safe at 1% Face and Hand Cosmetics; No Relevant Carcinogenic Concern at Topical Use Concentrations; Aspergillus oryzae Fermentation Byproduct; Melasma Treatment; Limited Dermal Penetration Log Kow -0.08; Aquatic Biodegradable (2014) — regulatory

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →